Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Candace S Johnson

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Epigenetics|July 5, 2011
Differential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostateKristin K Deeb, Wei Luo, Adam R Karpf, et al.
Cancers|March 19, 2020
Vitamin D3 Metabolites Demonstrate Prognostic Value in <i>EGFR</i>-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic ResistanceTatiana Shaurova, Grace K Dy, Sebastiano Battaglia, et al.
BMC Bioinformatics|April 19, 2015
SCNVSim: somatic copy number variation and structure variation simulatorMaochun Qin, Biao Liu, Jeffrey M Conroy, et al.
Cancer Medicine|April 12, 2019
Vitamin D<sub>3</sub> enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalkBrittany L Bunch, Yingyu Ma, Kristopher Attwood, et al.
BJU International|May 12, 2009
Vitamin D deficiency and insufficiency among patients with prostate cancerDonald L Trump, Manpreet K Chadha, Annette Y Sunga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumorsMarwan G Fakih, Donald L Trump, Josephia R Muindi, et al.
The Prostate|May 12, 2019
Association among plasma 1,25(OH)<sub>2</sub> D, ratio of 1,25(OH)<sub>2</sub> D to 25(OH)D, and prostate cancer aggressivenessSwathi Ramakrishnan, Susan E Steck, Lenore Arab, et al.
Plos One|April 29, 2015
Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaPSusan E Steck, Lenore Arab, Hongmei Zhang, et al.
Hormones & Cancer|March 5, 2013
Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genesJosephia R Muindi, Araba A Adjei, Zengru R Wu, et al.
The American Journal of Clinical Nutrition|May 4, 2018
Calcium, magnesium, and whole-milk intakes and high-aggressive prostate cancer in the North Carolina-Louisiana Prostate Cancer Project (PCaP)Susan E Steck, Omonefe O Omofuma, L Joseph Su, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Epigenetics|July 5, 2011
Differential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostateKristin K Deeb, Wei Luo, Adam R Karpf, et al.
Cancers|March 19, 2020
Vitamin D3 Metabolites Demonstrate Prognostic Value in <i>EGFR</i>-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic ResistanceTatiana Shaurova, Grace K Dy, Sebastiano Battaglia, et al.
BMC Bioinformatics|April 19, 2015
SCNVSim: somatic copy number variation and structure variation simulatorMaochun Qin, Biao Liu, Jeffrey M Conroy, et al.
Cancer Medicine|April 12, 2019
Vitamin D<sub>3</sub> enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalkBrittany L Bunch, Yingyu Ma, Kristopher Attwood, et al.
BJU International|May 12, 2009
Vitamin D deficiency and insufficiency among patients with prostate cancerDonald L Trump, Manpreet K Chadha, Annette Y Sunga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumorsMarwan G Fakih, Donald L Trump, Josephia R Muindi, et al.
The Prostate|May 12, 2019
Association among plasma 1,25(OH)<sub>2</sub> D, ratio of 1,25(OH)<sub>2</sub> D to 25(OH)D, and prostate cancer aggressivenessSwathi Ramakrishnan, Susan E Steck, Lenore Arab, et al.
Plos One|April 29, 2015
Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaPSusan E Steck, Lenore Arab, Hongmei Zhang, et al.
Hormones & Cancer|March 5, 2013
Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genesJosephia R Muindi, Araba A Adjei, Zengru R Wu, et al.
The American Journal of Clinical Nutrition|May 4, 2018
Calcium, magnesium, and whole-milk intakes and high-aggressive prostate cancer in the North Carolina-Louisiana Prostate Cancer Project (PCaP)Susan E Steck, Omonefe O Omofuma, L Joseph Su, et al.
Pageof 11